Follow the people · Insider
Paul Herendeen
Paul Herendeen files insider transactions with the SEC as a director of Elanco Animal Health (ELAN). We hold 1 disclosed purchase or sale filed since 25 September 2006, 1 of them in the last 90 days.
- Files forELAN
- Disclosed buys and sells1 in all, 1 in the last 90 days
- Last disclosure10 August 2026
Positions held
5 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 30 November 2021 — 7 August 2026Director · Elanco Animal Health (ELAN)9 Form 4 lines · source: SEC Form 4
- Filed 23 August 2018 — 10 March 2021EVP and CFO · Bausch Health Companies (BHC)20 Form 4 lines · source: SEC Form 4
- Filed 22 August 2016 — 13 March 2018EVP and CFO · Valeant Pharmaceuticals International (VRX)8 Form 4 lines · source: SEC Form 4
- Filed 2 September 2014 — 19 July 2016Exec. V.P. and CFO · Zoetis (ZTS)13 Form 4 lines · source: SEC Form 4
- Filed 21 September 2006 — 1 October 2013Exec. V.P. and CFO · Warner Chilcott (WCRX)39 Form 4 lines · source: SEC Form 4
Everything they disclosed
89 entries, newest first — one per disclosure report, one per Form 4 line- ▲ bought on the open market 10,000 shares of Elanco Animal HealthSEC Form 410 August 2026Common Stock · traded 7 August 2026 · filed 10 August 2026
- was granted 4,678 shares of Elanco Animal HealthSEC Form 426 May 2026Common Stock · traded 21 May 2026 · filed 26 May 2026
- was granted 12,196 shares of Elanco Animal HealthSEC Form 426 May 2026Common Stock · traded 21 May 2026 · filed 26 May 2026
- was granted 10,314 shares of Elanco Animal HealthSEC Form 42 December 2025Common Stock · traded 28 November 2025 · filed 2 December 2025
- was granted 18,169 shares of Elanco Animal HealthSEC Form 43 December 2024Common Stock · traded 29 November 2024 · filed 3 December 2024
- was granted 20,374 shares of Elanco Animal HealthSEC Form 44 December 2023Common Stock · traded 30 November 2023 · filed 4 December 2023
- was granted 18,649 shares of Elanco Animal HealthSEC Form 42 December 2022Common Stock · traded 30 November 2022 · filed 2 December 2022
- ▲ bought on the open market 10,000 shares of Elanco Animal HealthSEC Form 49 September 2022Common Stock · traded 9 September 2022 · filed 9 September 2022
- was granted 7,307 shares of Elanco Animal HealthSEC Form 42 December 2021Common Stock · traded 30 November 2021 · filed 2 December 2021
- exercised options over 49,324 shares of Bausch Health Companies (a derivative holding)SEC Form 410 March 2021Restricted Share Units · traded 8 March 2021 · filed 10 March 2021
- exercised options over 49,324 shares of Bausch Health CompaniesSEC Form 410 March 2021Common Shares, No Par Value · traded 8 March 2021 · filed 10 March 2021
- was granted 50,518 shares of Bausch Health CompaniesSEC Form 410 March 2021Common Shares, No Par Value · traded 8 March 2021 · filed 10 March 2021
- had shares withheld for tax on 59,519 shares of Bausch Health CompaniesSEC Form 410 March 2021Common Shares, No Par Value · traded 10 March 2021 · filed 10 March 2021
- was granted 63,439 shares of Bausch Health CompaniesSEC Form 45 March 2021Common Shares, No Par Value · traded 3 March 2021 · filed 5 March 2021
- was granted 91,684 shares of Bausch Health Companies (a derivative holding)SEC Form 45 March 2021Non-qualified Stock Options (right To Purchase) · traded 3 March 2021 · filed 5 March 2021
- had shares withheld for tax on 15,755 shares of Bausch Health CompaniesSEC Form 43 March 2021Common Shares, No Par Value · traded 1 March 2021 · filed 3 March 2021
- had shares withheld for tax on 1,642 shares of Bausch Health CompaniesSEC Form 416 September 2020Common Shares, No Par Value · traded 15 September 2020 · filed 16 September 2020
- had shares withheld for tax on 9,328 shares of Bausch Health CompaniesSEC Form 411 March 2020Common Shares, No Par Value · traded 9 March 2020 · filed 11 March 2020
- had shares withheld for tax on 7,167 shares of Bausch Health CompaniesSEC Form 43 March 2020Common Shares, No Par Value · traded 28 February 2020 · filed 3 March 2020
- was granted 159,192 shares of Bausch Health Companies (a derivative holding)SEC Form 428 February 2020Non-qualified Stock Options (right To Purchase) · traded 26 February 2020 · filed 28 February 2020
- was granted 63,030 shares of Bausch Health CompaniesSEC Form 428 February 2020Common Shares, No Par Value · traded 26 February 2020 · filed 28 February 2020
- had shares withheld for tax on 1,642 shares of Bausch Health CompaniesSEC Form 418 September 2019Common Stock, No Par Value · traded 16 September 2019 · filed 18 September 2019
- had shares withheld for tax on 24,625 shares of Bausch Health CompaniesSEC Form 427 August 2019Common Stock, No Par Value · traded 23 August 2019 · filed 27 August 2019
- had shares withheld for tax on 9,796 shares of Bausch Health CompaniesSEC Form 412 March 2019Common Stock, No Par Value · traded 8 March 2019 · filed 12 March 2019
- was granted 124,002 shares of Bausch Health Companies (a derivative holding)SEC Form 41 March 2019Non-qualified Stock Options (right To Purchase) · traded 27 February 2019 · filed 1 March 2019
- was granted 62,915 shares of Bausch Health CompaniesSEC Form 41 March 2019Common Stock, No Par Value · traded 27 February 2019 · filed 1 March 2019
- ▲ bought on the open market 10,000 shares of Bausch Health CompaniesSEC Form 417 September 2018Common Stock, No Par Value · traded 14 September 2018 · filed 17 September 2018
- was granted 10,000 shares of Bausch Health CompaniesSEC Form 417 September 2018Common Stock, No Par Value · traded 14 September 2018 · filed 17 September 2018
- had shares withheld for tax on 24,626 shares of Bausch Health CompaniesSEC Form 427 August 2018Common Stock, No Par Value · traded 23 August 2018 · filed 27 August 2018
- ▲ bought on the open market 15,000 shares of Valeant Pharmaceuticals InternationalSEC Form 413 March 2018Common Stock, No Par Value · traded 13 March 2018 · filed 13 March 2018
- was granted 177,482 shares of Valeant Pharmaceuticals International (a derivative holding)SEC Form 49 March 2018Non-qualified Stock Options (right To Purchase) · traded 7 March 2018 · filed 9 March 2018
- was granted 79,556 shares of Valeant Pharmaceuticals International (a derivative holding)SEC Form 49 March 2018Restricted Share Units · traded 7 March 2018 · filed 9 March 2018
- was granted 59,667 shares of Valeant Pharmaceuticals InternationalSEC Form 49 March 2018Common Stock, No Par Value · traded 7 March 2018 · filed 9 March 2018
- had shares withheld for tax on 17,175 shares of Valeant Pharmaceuticals InternationalSEC Form 425 August 2017Common Stock, No Par Value · traded 23 August 2017 · filed 25 August 2017
- ▲ bought on the open market 24,000 shares of Valeant Pharmaceuticals InternationalSEC Form 416 March 2017Common Stock, no par value · traded 14 March 2017 · filed 16 March 2017
- was granted 150,000 shares of Valeant Pharmaceuticals InternationalSEC Form 424 August 2016Common Stock, no par value · traded 22 August 2016 · filed 24 August 2016
- was granted 1,000,000 shares of Valeant Pharmaceuticals International (a derivative holding)SEC Form 424 August 2016Non-Qualified Stock Options (right to purchase) · traded 22 August 2016 · filed 24 August 2016
- was granted 531 shares of Zoetis (a derivative holding)SEC Form 420 July 2016Phantom Stock Unit · traded 19 July 2016 · filed 20 July 2016
- was granted 1,513 shares of Zoetis (a derivative holding)SEC Form 419 April 2016Phantom Stock Unit · traded 15 April 2016 · filed 19 April 2016
- was granted 2,013 shares of Zoetis (a derivative holding)SEC Form 44 March 2016Phantom Stock Unit · traded 3 March 2016 · filed 4 March 2016
- was granted 15,937 shares of Zoetis (a derivative holding)SEC Form 423 February 2016Restricted Stock Unit · traded 19 February 2016 · filed 23 February 2016
- was granted 59,577 shares of Zoetis (a derivative holding)SEC Form 423 February 2016Stock Option · traded 19 February 2016 · filed 23 February 2016
- was granted 569 shares of Zoetis (a derivative holding)SEC Form 414 January 2016Phantom Stock Unit · traded 13 January 2016 · filed 14 January 2016
- was granted 582 shares of Zoetis (a derivative holding)SEC Form 414 October 2015Phantom Stock Unit · traded 13 October 2015 · filed 14 October 2015
- was granted 532 shares of Zoetis (a derivative holding)SEC Form 410 July 2015Phantom Stock Unit · traded 9 July 2015 · filed 10 July 2015
- was granted 89 shares of Zoetis (a derivative holding)SEC Form 410 April 2015Phantom Stock Unit · traded 9 April 2015 · filed 10 April 2015
- was granted 13,018 shares of Zoetis (a derivative holding)SEC Form 43 March 2015Restricted Stock Unit · traded 27 February 2015 · filed 3 March 2015
- was granted 51,413 shares of Zoetis (a derivative holding)SEC Form 43 March 2015Stock Option · traded 27 February 2015 · filed 3 March 2015
- was granted 12,330 shares of Zoetis (a derivative holding)SEC Form 43 September 2014Restricted Stock Unit · traded 2 September 2014 · filed 3 September 2014
- was granted 50,636 shares of Zoetis (a derivative holding)SEC Form 43 September 2014Stock Option · traded 2 September 2014 · filed 3 September 2014
- returned to the issuer 36,610 shares of Warner Chilcott (a derivative holding)SEC Form 41 October 2013Performance Restricted Share Units · traded 30 September 2013 · filed 1 October 2013
- returned to the issuer 479,430 shares of Warner Chilcott (a derivative holding)SEC Form 41 October 2013Option to purchase ordinary shares par value $0.01 per share · traded 30 September 2013 · filed 1 October 2013
- returned to the issuer 111,920 shares of Warner Chilcott (a derivative holding)SEC Form 41 October 2013Option to purchase ordinary shares par value $0.01 per share · traded 30 September 2013 · filed 1 October 2013
- returned to the issuer 56,710 shares of Warner Chilcott (a derivative holding)SEC Form 41 October 2013Option to purchase ordinary shares par value $0.01 per share · traded 30 September 2013 · filed 1 October 2013
- returned to the issuer 49,180 shares of Warner Chilcott (a derivative holding)SEC Form 41 October 2013Option to purchase ordinary shares par value $0.01 per share · traded 30 September 2013 · filed 1 October 2013
- returned to the issuer 73,330 shares of Warner Chilcott (a derivative holding)SEC Form 41 October 2013Option to purchase ordinary shares par value $0.01 per share · traded 30 September 2013 · filed 1 October 2013
- returned to the issuer 129,340 shares of Warner Chilcott (a derivative holding)SEC Form 41 October 2013Option to purchase ordinary shares par value $0.01 per share · traded 30 September 2013 · filed 1 October 2013
- returned to the issuer 37,720 shares of Warner ChilcottSEC Form 41 October 2013Ordinary shares, par value $0.01 per share · traded 30 September 2013 · filed 1 October 2013
- returned to the issuer 94,900 shares of Warner ChilcottSEC Form 41 October 2013Ordinary shares, par value $0.01 per share · traded 1 October 2013 · filed 1 October 2013
- ▼ sold on the open market 4,674 shares of Warner ChilcottSEC Form 41 March 2013Ordinary shares, par value $0.01 per share · traded 28 February 2013 · filed 1 March 2013
- ▼ sold on the open market 1,969 shares of Warner ChilcottSEC Form 421 February 2013Ordinary shares, par value $0.01 per share · traded 19 February 2013 · filed 21 February 2013
- was granted 37,720 shares of Warner ChilcottSEC Form 415 February 2013Ordinary shares, par value $0.01 per share · traded 13 February 2013 · filed 15 February 2013
- was granted 36,610 shares of Warner Chilcott (a derivative holding)SEC Form 415 February 2013Performance Restricted Share Units · traded 13 February 2013 · filed 15 February 2013
- was granted 129,340 shares of Warner Chilcott (a derivative holding)SEC Form 415 February 2013Option to purchase ordinary shares par value $0.01 per share · traded 13 February 2013 · filed 15 February 2013
- ▼ sold on the open market 2,840 shares of Warner ChilcottSEC Form 44 February 2013Ordinary shares, par value $0.01 per share · traded 1 February 2013 · filed 4 February 2013
- ▼ sold on the open market 2,208 shares of Warner ChilcottSEC Form 431 January 2013Ordinary shares, par value $0.01 per share · traded 30 January 2013 · filed 31 January 2013
- ▼ sold on the open market 4,305 shares of Warner ChilcottSEC Form 423 January 2013Ordinary shares, par value $0.01 per share · traded 22 January 2013 · filed 23 January 2013
- ▼ sold on the open market 309,240 shares of Warner ChilcottSEC Form 412 September 2012Ordinary shares, par value $0.01 per share · traded 11 September 2012 · filed 12 September 2012
- ▼ sold on the open market 1,827 shares of Warner ChilcottSEC Form 42 March 2012Ordinary shares, par value $0.01 per share · traded 1 March 2012 · filed 2 March 2012
- ▼ sold on the open market 1,933 shares of Warner ChilcottSEC Form 423 February 2012Ordinary shares, par value $0.01 per share · traded 21 February 2012 · filed 23 February 2012
- was granted 73,330 shares of Warner Chilcott (a derivative holding)SEC Form 42 February 2012Option to purchase ordinary shares par value $0.01 per share · traded 31 January 2012 · filed 2 February 2012
- was granted 58,520 shares of Warner ChilcottSEC Form 42 February 2012Ordinary shares, par value $0.01 per share · traded 31 January 2012 · filed 2 February 2012
- ▼ sold on the open market 2,187 shares of Warner ChilcottSEC Form 431 January 2012Ordinary shares, par value $0.01 per share · traded 30 January 2012 · filed 31 January 2012
- ▼ sold on the open market 4,149 shares of Warner ChilcottSEC Form 424 January 2012Ordinary shares, par value $0.01 per share · traded 23 January 2012 · filed 24 January 2012
- ▼ sold on the open market 15,406 shares of Warner ChilcottSEC Form 431 March 2011Ordinary shares, par value $0.01 per share · traded 30 March 2011 · filed 31 March 2011
- ▼ sold on the open market 400,000 shares of Warner ChilcottSEC Form 417 March 2011Ordinary shares, par value $0.01 per share · traded 16 March 2011 · filed 17 March 2011
- was granted 49,180 shares of Warner Chilcott (a derivative holding)SEC Form 418 February 2011Option to purchase ordinary shares par value $0.01 per share · traded 17 February 2011 · filed 18 February 2011
- was granted 40,370 shares of Warner ChilcottSEC Form 418 February 2011Ordinary shares, par value $0.01 per share · traded 17 February 2011 · filed 18 February 2011
- ▼ sold on the open market 2,152 shares of Warner ChilcottSEC Form 41 February 2011Ordinary shares, par value $0.01 per share · traded 31 January 2011 · filed 1 February 2011
- ▼ sold on the open market 4,096 shares of Warner ChilcottSEC Form 424 January 2011Ordinary shares, par value $0.01 per share · traded 21 January 2011 · filed 24 January 2011
- gave away 12,000 shares of Warner ChilcottSEC Form 424 November 2010Ordinary shares, par value $0.01 per share · traded 24 November 2010 · filed 24 November 2010
- was granted 56,710 shares of Warner Chilcott (a derivative holding)SEC Form 42 February 2010Option to purchase ordinary shares par value $0.01 per share · traded 29 January 2010 · filed 2 February 2010
- was granted 22,970 shares of Warner ChilcottSEC Form 42 February 2010Ordinary shares, par value $0.01 per share · traded 29 January 2010 · filed 2 February 2010
- ▼ sold on the open market 4,120 shares of Warner ChilcottSEC Form 422 January 2010Ordinary shares, par value $0.01 per share · traded 21 January 2010 · filed 22 January 2010
- ▼ sold on the open market 147,846 shares of Warner ChilcottSEC Form 430 November 2009Ordinary shares, par value $0.01 per share · traded 25 November 2009 · filed 30 November 2009
- was granted 111,920 shares of Warner Chilcott (a derivative holding)SEC Form 422 January 2009Options to purchase Class A common shares, par value $0.01 · traded 20 January 2009 · filed 22 January 2009
- was granted 42,450 shares of Warner ChilcottSEC Form 422 January 2009Class A common shares, par value $0.01 per share · traded 20 January 2009 · filed 22 January 2009
- was granted 178,527 shares of Warner ChilcottSEC Form 425 September 2006Class A common shares, par value $0.01 per share · traded 21 September 2006 · filed 25 September 2006
- had shares withheld for tax on 81,230 shares of Warner ChilcottSEC Form 425 September 2006Class A common shares, par value $0.01 per share · traded 21 September 2006 · filed 25 September 2006
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.